Veru Receives Positive Input from FDA on Phase 3 Pivotal Trial to Evaluate VERU-111 in Metastatic Castration Resistant Prostate Cancer

Author's Avatar
Jul 23, 2020
Article's Main Image

--Pivotal Phase 3 Clinical Trial Expected to Initiate First Quarter Calendar Year 2021--